The interview with Nicola Petrosillo
di Beatrice Passarelli
7 April 2022 - Prof. Nicola Petrosillo, head of the infection control service, the virus today is different from the one identified in China. Will it be necessary to adjust vaccines? To ensure their effectiveness against the most circulating variants, the new vaccines will need to be updated. The one of the future, the so-called "pan-vaccine", will not stimulate the immune response only against the spike protein, but against all the components of the pathogen.
Monoclonal antibodies and oral antivirals: how and when are they indicated? They are both powerful tools in the treatment of Covid-19 in individuals with clinical conditions considered risk factors for progression of the disease to its most severe form. The timeliness with which the patient, within five days of the onset of symptoms, communicates his state of health to the family doctor is crucial.
When the symptoms of Covid-19 persist we speak of long-Covid. How much do we know so far? The distant manifestations of the disease contain many nuances, some of which are still unknown. Those who have had a serious illness have a greater chance of incurring complications, but even those who have had mild forms can experience signs and symptoms that will be essential to study in depth in the future.
